Literature DB >> 505486

Circulating platelet aggregates in sickle cell disease patients with and without vaso-occlusion.

P Mehta, J Mehta.   

Abstract

In vivo circulating platelet aggregates (CPA) were evaluated in 18 patients aged 6 to 17 years with sickle cell disease and in 11 age and sex matched normal subjects. Twelve patients with sickle cell disease were in steady state and 6 had vaso-occlusive crises. CPA in patients in steady state were similar to those in normal subjects (mean 6 +/- 1% compared to 5 +/- 2%, respectively), whereas patients with vaso-occlusive crisis in acute state had significantly higher CPA (mean 39 +/- 8%) than patients in steady state or normal control individuals (both p less than 0.001). CPA decreased in patients with vaso-occlusive crisis (mean 11 +/- 4%) on the tenth day, in association with clinical improvement. This study suggests that in vivo platelet aggregate formation activity, although normal in sickle cell disease patients in steady state, is significantly increased in patients with vaso-occlusive crises.

Entities:  

Mesh:

Year:  1979        PMID: 505486     DOI: 10.1161/01.str.10.4.464

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

1.  Evaluation of clinical severity in sickle cell disease.

Authors:  B F Cameron; E Christian; J S Lobel; M H Gaston
Journal:  J Natl Med Assoc       Date:  1983-05       Impact factor: 1.798

2.  Morphological and functional platelet abnormalities in Berkeley sickle cell mice.

Authors:  Arun S Shet; Thomas J Hoffmann; Marketa Jirouskova; Christin A Janczak; Jacqueline R M Stevens; Adewole Adamson; Narla Mohandas; Elizabeth A Manci; Therese Cynober; Barry S Coller
Journal:  Blood Cells Mol Dis       Date:  2008-04-18       Impact factor: 3.039

3.  Hematological parameters in sickle cell anemia patients with and without priapism.

Authors:  Sagir G Ahmed; Umma A Ibrahim; Abba W Hassan
Journal:  Ann Saudi Med       Date:  2006 Nov-Dec       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.